Remove 2019 Remove Clinical Trials Remove Epilepsy Remove History
article thumbnail

Cannabis laws in Japan: Is weed legal?

The Cannigma

However, the country has a history of cannabis art dating back millenia , and scholars believe that the plant was used for centuries as a textile and for use in traditional Shinto ceremonies. But in modern times? That could potentially change in the near future, however. Amphetamines are the most popular drug of choice in Japan.).

Law 137
article thumbnail

NORML 2019 Legislative Report

Cannabis Law Report

This report contains a detailed summary of 2019’s federal and state legislative victories.” 2019 has been an unprecedented year for the passage of state-level marijuana law reforms. “Never before in American history has marijuana policy advanced in Congress as far or as fast in one year as 2019.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Guest Post: Is CBD Legal? Federal & State Laws [2019]

Cannabis Law Report

Although the DEA refuses to remove marijuana from the schedule 1 list, the Farm Bill is considered to be the most important victory in the history of U.S. THC for patients who suffer from severe epilepsy and is produced in compliance with the North Carolina Industrial Hemp Commission regulations.

article thumbnail

Use of Cannabis-based medicinal products: NICE guidelines

Cannabis Law Report

NICE guideline [NG144] Published date: November 2019. Severe treatment-resistant epilepsy. Severe treatment-resistant epilepsy. Do not offer CBD to manage chronic pain in adults unless as part of a clinical trial. 1.4 Severe treatment-resistant epilepsy. Cannabis-based medicinal products. Chronic pain.

article thumbnail

And Here We Go Again! NASDAQ Article: Forget Cannabis: Psychedelic Medicine Is the Better Investing Opportunity

Cannabis Law Report

First up, cannabis has now been scientifically validated as a treatment for two severe forms of childhood epilepsy (more on this in a moment). In March 2019, J&J’s hard work paid off when the FDA approved Spravato for treatment-resistant depression. Potential IPOs within the next year.

article thumbnail

Jones Day: The life sciences regulatory regime in Australia

Cannabis Law Report

One such circumstance is a clinical trial. A clinical trial in Australia must have an Australian sponsor (whether it be an individual (e.g., Two of the avenues for supply of UTGs for clinical trials are the Clinical Trial Exemption (CTX) Scheme and the Clinical Trial Notification (CTN) Scheme.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Using a content analysis approach, we investigated articles about medicinal cannabis from 2000 to the end of 2019 in the Medical Journal of Australia, Australian Doctor , Medical Observer , Australian Journal of General Practice , Australian Family Physicia n , and Australian Medicine. Refractory paediatric epilepsy. Conclusions.